Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EGFR L747P

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR L747P	Non Small Cell Lung Cancer	EGFR L747P	Non Small Cell Lung Cancer	dacomitinib Sensitive: C3 – Early Trials Transl Cancer Res - 2 weeks (New C3) dacomitinib Sensitive : C3 Transl Cancer Res - 2wk	dacomitinib Sensitive: C3 – Early Trials Transl Cancer Res - 2 weeks dacomitinib Sensitive : C3 Transl Cancer Res - 2 weeks - (New C3)
EGFR L747P	Non Small Cell Lung Cancer	EGFR L747P	Non Small Cell Lung Cancer	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
EGFR L747P	Lung Adenocarcinoma	EGFR L747P	Lung Adenocarcinoma	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
EGFR L747P	Lung Adenocarcinoma	EGFR L747P	Lung Adenocarcinoma	gefitinib Sensitive: C4 – Case Studies gefitinib Sensitive : C4	gefitinib Sensitive: C4 – Case Studies gefitinib Sensitive : C4
EGFR L747P	Lung Adenocarcinoma	EGFR L747P	Lung Adenocarcinoma	osimertinib Sensitive: C4 – Case Studies osimertinib Sensitive : C4	osimertinib Sensitive: C4 – Case Studies osimertinib Sensitive : C4
EGFR L747P	Non Small Cell Lung Cancer	EGFR L747P	Non Small Cell Lung Cancer	gefitinib Resistant: C4 – Case Studies gefitinib Resistant : C4	gefitinib Resistant: C4 – Case Studies gefitinib Resistant : C4
EGFR L747P	Lung Adenocarcinoma	EGFR L747P	Lung Adenocarcinoma	erlotinib Sensitive: C4 – Case Studies erlotinib Sensitive : C4	erlotinib Sensitive: C4 – Case Studies erlotinib Sensitive : C4